Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Top Cited Papers
- 9 February 2023
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 68, 100938
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapyMolecular Cancer, 2014
- Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivoOncology Letters, 2013
- miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancerBMC Medical Genomics, 2012
- Mcl‐1; the molecular regulation of protein functionFEBS Letters, 2010
- The Chemical Biology of Protein PhosphorylationAnnual Review of Biochemistry, 2009
- Long non-coding RNAs: insights into functionsNature Reviews Genetics, 2009
- UCA1, a non‐protein‐coding RNA up‐regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasionFEBS Letters, 2008
- Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic reviewCancer Treatment Reviews, 2007
- Preclinical studies identifying carboplatin as a viable cisplatin alternativeCancer Treatment Reviews, 1985
- Antitumor activity of 1,2-diaminocyclohexaneplatinum complexes against Sarcoma-180 ascites formJournal of Medicinal Chemistry, 1978